{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase", "item": "https://www.patentleaderboard.com/patent/6057320"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

US Patent 6057320 · Granted May 2, 2000

Estimated economic value: $5,297,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Caspase inhibitors and methods of use thereof2024
Modified collagen2023
Collagen powder2023
Caspase inhibitors and methods of use thereof2023
(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluoro2022
Drug delivery device for providing local analgesia, local anesthesia or nerve bl2020
Modified collagen2019
Highly water-soluble salts of a short acting phenylalkylamine calcium channel bl2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2017